 prevent nosocomi lung infect ventil patient use antimicrobi pharyng nonabsorb past compar prospect studi incid infect airway purul tracheobronch pneumonia long-term patient due respiratori failur noninfecti origin twenty-eight patient studi group nonabsorb past tobramycin amphotericin polymyxin oropharynx control group past antibiot oropharynx effect prophylact techniqu oropharynx trachea organ pathogen respiratori system decontamin success ten patient group patient group result rate infect respiratori tract studi group patient tracheobronch pneumonia control group patient tracheobronch pneumonia differ signific patient group sepsi pulmonari origin none patient prophylact treatment complic overal mortal similar group group group infect great extent death patient group nosocomi pneumonia frequent complic ill patient mechan ventil local applic nonabsorb antibiot oropharynx